Capecitabine may interact with "blood thinners" (anticoagulants such as warfarin or phenprocoumon) and cause serious, rarely fatal bleeding. In some cases, this bleeding has occurred up to one month after stopping capecitabine as well as during treatment.
If you are using an anticoagulant, your laboratory tests (INR/PT) will be closely monitored. Report any signs of bleeding or bruising (such as black stools) to your...
Read moreThe annual San Antonio Breast Cancer Symposium (SABCS), held last month, is the premier scientific symposium in the world for breast... Read more »
Q. I've been taking Herceptin for quite some time for my advanced HER2-positive breast cancer. The Herceptin worked for awhile, but... Read more »
Source: Breastcancer.org
Brand name: Xeloda Chemical name: Capecitabine Class: Antimetabolite chemotherapy. Fluorouracil, Gemzar, and methotrexate are other... Read more »
Drugmaker Pfizer has stopped a late-stage trial on the drug Sutent because it was not proving effective for patients with advanced breast cancer. In... Read more »
Source: Breastcancer.org
Tykerb can cause some side effects that are usually not severe and can be treated successfully. The most common side effects... Read more »
Source: Breastcancer.org
Tykerb is prescribed with the chemotherapy medication Xeloda or with the hormonal therapy medicine Femara. All three medicines are pills that are... Read more »
A new study suggests that taking Tykerb along with the cancer med Xeloda may help reduce brain tumors in women whose breast cancer has spread.... Read more »